HB1056 - State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution
Maryland - 2024 Regular Session
Introduced byPamela Lanman Guzzone, Heather Bagnall, Terri Hill
Last updated 5 months ago
23 Co-Sponsors
Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Consumer Protection Act; and requiring the Maryland Prescription Drug Affordability Board to conduct a study of the 340B Program and report its findings and recommendations to certain committees of the General Assembly by July 1, 2026.
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.